Cargando…
Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against cathepsin D
Plasmepsins (Plms) are aspartic proteases involved in the degradation of human hemoglobin by P. falciparum and are essential for the survival and growth of the parasite. Therefore, Plm enzymes are reported as an important antimalarial drug target. Herein, we have applied molecular docking, molecular...
Autores principales: | Martins, Lucas Sousa, Kruger, Hendrik Gerhardus, Naicker, Tricia, Alves, Cláudio Nahum, Lameira, Jerônimo, Araújo Silva, José Rogério |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773328/ https://www.ncbi.nlm.nih.gov/pubmed/36605626 http://dx.doi.org/10.1039/d2ra06246a |
Ejemplares similares
-
Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D
por: Zogota, Rimants, et al.
Publicado: (2019) -
Evaluating the Performance of a Non-Bonded Cu(2+) Model Including Jahn−Teller Effect into the Binding of Tyrosinase Inhibitors
por: Martins, Lucas Sousa, et al.
Publicado: (2020) -
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
por: Richardson, Lachlan W., et al.
Publicado: (2022) -
Macrocyclic
Peptidomimetic Plasmepsin X Inhibitors
with Potent In Vitro and In Vivo Antimalarial Activity
por: Kovada, Vadims, et al.
Publicado: (2023) -
Pentacycloundecane lactam vs lactone norstatine type protease HIV inhibitors: binding energy calculations and DFT study
por: Honarparvar, Bahareh, et al.
Publicado: (2015)